Association between antenatal diagnosis of late fetal growth restriction and educational outcomes in mid-childhood: A UK prospective cohort study with long-term data linkage study
- PMID: 37093852
- PMCID: PMC10166482
- DOI: 10.1371/journal.pmed.1004225
Association between antenatal diagnosis of late fetal growth restriction and educational outcomes in mid-childhood: A UK prospective cohort study with long-term data linkage study
Abstract
Background: Fetal growth restriction (FGR) is associated with a suboptimal intrauterine environment, which may adversely impact fetal neurodevelopment. However, analysing neurodevelopmental outcomes by observed birthweight fails to differentiate between true FGR and constitutionally small infants and cannot account for iatrogenic intervention. This study aimed to determine the relationship between antenatal FGR and mid-childhood (age 5 to 7 years) educational outcomes.
Methods and findings: The Pregnancy Outcome Prediction Study (2008-2012) was a prospective birth cohort conducted in a single maternity hospital in Cambridge, United Kingdom. Clinicians were blinded to the antenatal diagnosis of FGR. FGR was defined as estimated fetal weight (EFW) <10th percentile at approximately 36 weeks of gestation, plus one or more indicators of placental dysfunction, including ultrasonic markers and maternal serum levels of placental biomarkers. A total of 2,754 children delivered at term were divided into 4 groups: FGR, appropriate-for-gestational age (AGA) with markers of placental dysfunction, healthy small-for-gestational age (SGA), and healthy AGA (referent). Educational outcomes (assessed at 5 to 7 years using UK national standards) were assessed with respect to FGR status using regression models adjusted for relevant covariates, including maternal, pregnancy, and socioeconomic factors. Compared to healthy AGA (N = 1,429), children with FGR (N = 250) were at higher risk of "below national standard" educational performance at 6 years (18% versus 11%; aOR 1.68; 95% CI 1.12 to 2.48, p = 0.01). By age 7, children with FGR were more likely to perform below standard in reading (21% versus 15%; aOR 1.46; 95% CI 0.99 to 2.13, p = 0.05), writing (28% versus 23%; aOR 1.46; 95% CI 1.02 to 2.07, p = 0.04), and mathematics (24% versus 16%; aOR 1.49; 95% CI 1.02 to 2.15, p = 0.03). This was consistent whether FGR was defined by ultrasound or biochemical markers. The educational attainment of healthy SGA children (N = 126) was comparable to healthy AGA, although this comparison may be underpowered. Our study design relied on linkage of routinely collected educational data according to nationally standardised metrics; this design allowed a high percentage of eligible participants to be included in the analysis (75%) but excludes those children educated outside of government-funded schools in the UK. Our focus on pragmatic and validated measures of educational attainment does not exclude more subtle effects of the intrauterine environment on specific aspects of neurodevelopment.
Conclusions: Compared to children with normal fetal growth and no markers of placental dysfunction, FGR is associated with poorer educational attainment in mid-childhood.
Copyright: © 2023 Olga et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests: GS has no direct conflict of interest. GS has received research support from Roche Diagnostics Ltd, Illumina and Sera Prognostics (fetal growth restriction, preeclampsia and preterm birth). GS’s department has received payment from Roche for a talk given by GS (fetal growth restriction). GS has been a paid consultant to GSK (preterm birth) and is a member of a Data Monitoring Committee for GSK trials of RSV vaccination in pregnancy. GS and US are two of three named inventors on a patent application (PCT/GB2020/053312) filed by Cambridge Enterprise for novel predictive test for fetal growth disorder. GS serves on PLOS Medicine’s editorial board. The other authors have no conflicts of interest including financial interests, activities, relationships, and affiliations to declare.
Figures

Similar articles
-
Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.Cochrane Database Syst Rev. 2019 May 14;5(5):CD012245. doi: 10.1002/14651858.CD012245.pub2. Cochrane Database Syst Rev. 2019. PMID: 31087568 Free PMC article.
-
Association Between Iatrogenic Delivery for Suspected Fetal Growth Restriction and Childhood School Outcomes.JAMA. 2021 Jul 13;326(2):145-153. doi: 10.1001/jama.2021.8608. JAMA. 2021. PMID: 34255007 Free PMC article.
-
Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweight.BMC Med. 2020 Dec 24;18(1):395. doi: 10.1186/s12916-020-01869-3. BMC Med. 2020. PMID: 33357243 Free PMC article.
-
Application of Prospect Theory in Obstetrics by Evaluating Mode of Delivery and Outcomes in Neonates Born Small or Appropriate for Gestational Age.JAMA Netw Open. 2022 Mar 1;5(3):e222177. doi: 10.1001/jamanetworkopen.2022.2177. JAMA Netw Open. 2022. PMID: 35289859 Free PMC article.
-
Association of Intrauterine Growth Restriction and Small for Gestational Age Status With Childhood Cognitive Outcomes: A Systematic Review and Meta-analysis.JAMA Pediatr. 2020 Aug 1;174(8):772-781. doi: 10.1001/jamapediatrics.2020.1097. JAMA Pediatr. 2020. PMID: 32453414 Free PMC article.
Cited by
-
Intrauterine Growth Restriction: Need to Improve Diagnostic Accuracy and Evidence for a Key Role of Oxidative Stress in Neonatal and Long-Term Sequelae.Cells. 2024 Mar 13;13(6):501. doi: 10.3390/cells13060501. Cells. 2024. PMID: 38534344 Free PMC article. Review.
-
Impact of early-onset fetal growth restriction on the neurodevelopmental outcome of very preterm infants at 24 months: a retrospective cohort study.BMC Pediatr. 2023 Oct 26;23(1):533. doi: 10.1186/s12887-023-04361-y. BMC Pediatr. 2023. PMID: 37884935 Free PMC article.
-
Maternal Prenatal Depressive Symptoms and Fetal Growth During the Critical Rapid Growth Stage.JAMA Netw Open. 2023 Dec 1;6(12):e2346018. doi: 10.1001/jamanetworkopen.2023.46018. JAMA Netw Open. 2023. PMID: 38048129 Free PMC article.
-
Paternal lipopolysaccharide exposure induced intrauterine growth restriction via the inactivation of placental MEST/PI3K/AKT pathway in mice.Arch Toxicol. 2023 Nov;97(11):2929-2941. doi: 10.1007/s00204-023-03584-3. Epub 2023 Aug 21. Arch Toxicol. 2023. PMID: 37603095
-
Utility of whole exome sequencing in the evaluation of isolated fetal growth restriction in normal chromosomal microarray analysis.Ann Med. 2025 Dec;57(1):2476038. doi: 10.1080/07853890.2025.2476038. Epub 2025 Mar 11. Ann Med. 2025. PMID: 40066675 Free PMC article.
References
-
- Gaccioli F, Lager S, Sovio U, Charnock-Jones DS, Smith GCS. The pregnancy outcome prediction (POP) study: Investigating the relationship between serial prenatal ultrasonography, biomarkers, placental phenotype and adverse pregnancy outcomes. Placenta. 2017;59(Suppl 1):S17–S25.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous